These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 10328468)

  • 21. An observational study examining the effects of a surgically induced inflammatory response on the distribution of morphine and its metabolites into cerebrospinal fluid.
    Wang Y; Goralski KB; Roberts DJ; Landry K; Issa ME; Sleno L; Julien LC; Wood J; Hall RI
    Can J Anaesth; 2017 Oct; 64(10):1009-1022. PubMed ID: 28710563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig.
    Milne RW; Jensen RH; Larsen C; Evans AM; Nation RL
    Pharm Res; 1997 Aug; 14(8):1014-8. PubMed ID: 9279882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic modeling of morphine and its glucuronides: Comparison of nebulization versus intravenous route in healthy volunteers.
    Duflot T; Pereira T; Tavolacci MP; Joannidès R; Aubrun F; Lamoureux F; Lvovschi VE
    CPT Pharmacometrics Syst Pharmacol; 2022 Jan; 11(1):82-93. PubMed ID: 34842366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose.
    Velez de Mendizabal N; Jimenez-Mendez R; Cooke E; Montgomery CJ; Dawes J; Rieder MJ; Aleksa K; Koren G; Jacobo-Cabral CO; Gonzalez-Ramirez R; Castañeda-Hernandez G; Carleton BC
    Clin Pharmacokinet; 2015 Oct; 54(10):1083-90. PubMed ID: 25773480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients.
    Klepstad P; Borchgrevink PC; Dale O; Zahlsen K; Aamo T; Fayers P; Fougner B; Kaasa S
    Palliat Med; 2003 Dec; 17(8):679-87. PubMed ID: 14694919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions.
    Barrett DA; Barker DP; Rutter N; Pawula M; Shaw PN
    Br J Clin Pharmacol; 1996 Jun; 41(6):531-7. PubMed ID: 8799518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphine metabolite pharmacokinetics during venoarterial extra corporeal membrane oxygenation in neonates.
    Peters JW; Anderson BJ; Simons SH; Uges DR; Tibboel D
    Clin Pharmacokinet; 2006; 45(7):705-14. PubMed ID: 16802851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative disposition of morphine-3-glucuronide during separate intravenous infusions of morphine and morphine-3-glucuronide in sheep. Importance of the kidney.
    Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
    Drug Metab Dispos; 1995 Mar; 23(3):334-42. PubMed ID: 7628298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.
    Meineke I; Freudenthaler S; Hofmann U; Schaeffeler E; Mikus G; Schwab M; Prange HW; Gleiter CH; Brockmöller J
    Br J Clin Pharmacol; 2002 Dec; 54(6):592-603. PubMed ID: 12492606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine.
    Somogyi AA; Nation RL; Olweny C; Tsirgiotis P; van Crugten J; Milne RW; Cleary JF; Danz C; Bochner F
    Clin Pharmacokinet; 1993 May; 24(5):413-20. PubMed ID: 8504624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain.
    Goucke RC; Hackett PL; Ilett KF
    Pain; 1994 Feb; 56(2):145-149. PubMed ID: 8008404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
    Milne RW; Sloan PA; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
    Drug Metab Dispos; 1993; 21(6):1151-6. PubMed ID: 7905398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disposition of morphine and its glucuronide metabolites after oral and rectal administration: evidence of route specificity.
    Babul N; Darke AC
    Clin Pharmacol Ther; 1993 Sep; 54(3):286-92. PubMed ID: 8375123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain.
    Hunt A; Joel S; Dick G; Goldman A
    J Pediatr; 1999 Jul; 135(1):47-55. PubMed ID: 10393603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration.
    Wolff T; Samuelsson H; Hedner T
    Pain; 1995 Aug; 62(2):147-154. PubMed ID: 8545139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients.
    Ashby M; Fleming B; Wood M; Somogyi A
    J Pain Symptom Manage; 1997 Sep; 14(3):157-67. PubMed ID: 9291702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
    Holthe M; Klepstad P; Zahlsen K; Borchgrevink PC; Hagen L; Dale O; Kaasa S; Krokan HE; Skorpen F
    Eur J Clin Pharmacol; 2002 Aug; 58(5):353-6. PubMed ID: 12185559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous assay of morphine, morphine-3-glucuronide and morphine-6-glucuronide in human plasma using normal-phase liquid chromatography-tandem mass spectrometry with a silica column and an aqueous organic mobile phase.
    Naidong W; Lee JW; Jiang X; Wehling M; Hulse JD; Lin PP
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 735(2):255-69. PubMed ID: 10670739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of Morphine and Morphine-6-Glucuronide During Postoperative Pain Therapy in Cardiac Surgery Patients.
    Ihmsen H; Schüttler J; Jeleazcov C
    Eur J Drug Metab Pharmacokinet; 2021 Mar; 46(2):249-263. PubMed ID: 33547559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration.
    Peterson GM; Randall CT; Paterson J
    Eur J Clin Pharmacol; 1990; 38(2):121-4. PubMed ID: 2338107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.